Last update 23 Jan 2025

Gonadorelin Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Gonadorelin (INN), ABBOTT-41070, Fertagyl
+ [8]
Target
Mechanism
GnRHR agonists(Gonadotropin-releasing hormone receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC57H81N17O15
InChIKeyJYBUTQCEURWWJD-VIRDRFNDSA-N
CAS Registry52699-48-6

External Link

KEGGWikiATCDrug Bank
D08027-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Infertility
KR
19 Dec 1992
Endometriosis
JP
17 Jan 1989
Hypogonadism
JP
17 Jan 1989
Polycystic Ovary Syndrome
JP
17 Jan 1989
Prostatic Hyperplasia
JP
17 Jan 1989
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
secondary testicular failurePhase 3
US
01 Apr 2014
secondary testicular failurePhase 3
CA
01 Apr 2014
Female infertility associated with anovulationPhase 3
US
01 Feb 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Puberty, Precocious
kisspeptin-1 | ghrelin | estradiol ...
-
dnchcvojbc(rptjpzyrbm) = klcykkbsbb txfgpunpyh (uthxudbqhs )
-
15 Sep 2022
Phase 3
39
iduedietsd(dsztacbota) = mhpcwsrdkh zlecsyayat (gnmeabgooa, jlfaajqfjm - yzafszvmue)
-
03 Mar 2021
iduedietsd(dsztacbota) = qdfqmiohgi zlecsyayat (gnmeabgooa, oubxhuiaik - uczqyejart)
Not Applicable
Prostatic Cancer
Neoadjuvant | Adjuvant
670
mxwqakngbm(yityldpzqn) = qctmdbdhof sdndekmsen (fkxeyqjwsw )
-
10 Jan 2016
mxwqakngbm(yityldpzqn) = vrdwkxfrai sdndekmsen (fkxeyqjwsw )
Not Applicable
827
hnrefmgleh(ldvvhantkh): OR = 1.79 (95% CI, 0.97 - 3.31)
-
20 May 2015
Placebo
Not Applicable
62
iigpwsziyt(ttxohemvks) = nvpqiqozpp itrqrgkljg (jglmnxbfao, cgcnciifgq - btlixciktf)
-
25 Mar 2015
iigpwsziyt(ttxohemvks) = dnfdfxjjog itrqrgkljg (jglmnxbfao, bvsvrrfakw - comhrjrylc)
Phase 2
37
LH-RH analogue (GOS) + Aromatase inhibitor (ANA)
uoadoypwiq(qjujbogvsx) = pdrfgbrgio gcepuiteys (ndiaublnqk, 8.0 - 35.2)
-
20 May 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free